Humans have known for centuries that copper is a potent weapon against infection. New research shows that the bacteria that cause serious urinary tract infections know this, too, and steal copper to prevent the metal from being used against them.
An immune cell called a neutrophil (shown in light blue) attacks bacteria that cause urinary tract infections. Scientists have discovered that the bacteria can steal copper, a naturally occurring antimicrobial, from the host to prevent the metal from being used to fight infection.
Humans have known for centuries that copper is a potent weapon against infection. New research shows that the bacteria that cause serious urinary tract infections know this, too, and steal copper to prevent the metal from being used against them.
Â
Blocking this thievery with a drug may significantly improve patients chances of fighting off infections, according to researchers at Washington University School of Medicine in St. Louis. The findings appear online July 8 in Nature Chemical Biology.
In the United States alone, annual treatment costs for urinary tract infections are estimated to run as high as $1.6 billion. Most urinary tract infections are caused by Escherichia coli (E. coli).
While some patients are able to clear these infections without issue, in others the infection persists or recurs despite antibiotic therapy, says senior author Jeff Henderson, MD, PhD, assistant professor of medicine and of molecular microbiology. In some cases, the infection spreads to the kidney or the blood and becomes life-threatening. Weve been investigating whats different about the bacteria that cause these more troublesome infections.
Scientists have known for years that E. coli makes a molecule called yersiniabactin that takes iron from host cells. The bacteria need the iron to grow and reproduce.
In earlier research, Henderson found that the E. coli that cause serious infections are more likely to make yersiniabactin. This finding and the fact that E. coli already produce another molecule that steals iron led Henderson and Kaveri Chaturvedi, a student in his laboratory, to suspect that the bacterium might be using yersiniabactin for other purposes.
To test the theory, the researchers put yersiniabactin in urine samples from healthy patients. They found the molecule bound iron as expected but also picked up copper. Next, they conducted the same analysis in samples from patients with urinary tract infections who were treated at the University of Washington in Seattle.
We found copper bound to yersiniabactin in nearly every patient whose bacteria made the molecule, Henderson says. Yersiniabactin was often bound to copper more than it was to iron.
When researchers put E. coli in the same test tube with copper, the bacteria that made yersiniabactin were more likely to survive.
Coppers microbe-fighting properties were recognized long before scientists had described the microbes that cause infection. Ancient Greeks and Egyptians knew that treating wounds with copper improved the healing process.
Modern researchers have two explanations for coppers anti-microbial effects: the metal can stimulate production of other chemically reactive molecules that damage bacteria; and it is also directly toxic to the bacteria.
Henderson, who treats patients with urinary tract infections at Barnes-Jewish Hospital, is currently studying whether the presence or absence of yersiniabactin can help physicians assess an infections chances of becoming more serious.
He and his colleagues are also looking at other disease-causing bacteria that make yersiniabactin to see if they use it in a fashion similar to the E. coli that cause urinary tract infections.
Chaturvedi KS, Hung CS, Crowley JR, Stapleton AE, Henderson JP. The siderophore yersiniabactin bids copper to protect pathogens during infection. Nature Chemical Biology, July 8, 2012.
Funding from the Burroughs-Wellcome Fund and the National Institutes of Health supported this research.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.